{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:38Z","timestamp":1761919778719,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.msard.2013.12.007","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T20:20:02Z","timestamp":1388780402000},"page":"321-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-1088","authenticated-orcid":false,"given":"Reza","family":"Vosoughi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2013.12.007_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1042819021000055066","article-title":"Vascular events associated with alpha interferon therapy","volume":"44","author":"Al-Zahrani","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.msard.2013.12.007_bib5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.msard.2013.12.007_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.51.6.1720","article-title":"Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b","volume":"51","author":"Bramanti","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2013.12.007_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5414\/CN106523","article-title":"Thrombotic microangiopathy induced by long-term interferon-\u03b2 therapy for multiple sclerosis: a case report","volume":"76","author":"Broughton","year":"2011","journal-title":"Clin Nephrol"},{"issue":"Suppl. 2","key":"10.1016\/j.msard.2013.12.007_bib12","first-page":"A135","article-title":"Occurrence of a TTP-like syndrome in two women receiving beta interferon therapy for relapsing multiple sclerosis","volume":"52","author":"Herrera","year":"1999","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2013.12.007_bib15","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1352458512441272","article-title":"Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis","volume":"18","author":"Modrego","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2013.12.007_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJNRD.S30194","article-title":"Thrombotic microangiopathy associated with use of interferon-beta","volume":"5","author":"Olea","year":"2012","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.msard.2013.12.007_bib16","article-title":"Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis","author":"Orvain","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"9139","key":"10.1016\/j.msard.2013.12.007_bib3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","volume":"352","author":"PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.msard.2013.12.007_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000040905","article-title":"Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients","volume":"100","author":"Rachmani","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.msard.2013.12.007_bib6","first-page":"310596","article-title":"Thrombotic microangiopathies","volume":"2012","author":"Radhi","year":"2012","journal-title":"ISRN Hematol"},{"issue":"12","key":"10.1016\/j.msard.2013.12.007_bib2","first-page":"S25","article-title":"Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis","volume":"57","author":"Rudick","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2013.12.007_bib7","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/j.1468-1331.2010.03098.x","article-title":"Concomitant multiple sclerosis and idiopathic thrombocytopenic purpura","volume":"17","author":"Sahraian","year":"2010","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.msard.2013.12.007_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"43","author":"The IFNB Multiple Sclerosis Study Group","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2013.12.007_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000045147","article-title":"Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C","volume":"80","author":"Ubara","year":"1998","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.msard.2013.12.007_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-200207000-00008","article-title":"Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature","volume":"81","author":"Zuber","year":"2002","journal-title":"Medicine (Baltimore)"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:35:46Z","timestamp":1761899746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034813001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2211034813001624"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2013.12.007","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}